TY - JOUR
T1 - Vanishing white matter disease
AU - van der Knaap, Marjo S.
AU - Pronk, Jan C.
AU - Scheper, Gert C.
N1 - Funding Information:
We would like to thank all patients, families, and colleagues who contributed to our studies. Financial support for our work was provided by the Dutch Organisation for Scientific Research (NWO, grant 903-42-097), the “Princes Beatrix Fonds” (grant MAR01-0201), Dr WM Phelps Stichting (grant 03.030), and the Optimix Foundation for Scientific Research. The funding sources had no direct involvement with the contents of the studies in any way. Human tissue was obtained from the Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore. J M Powers, a neuropathologist at the University of Rochester, is acknowledged for critical reading of the review. P J van der Voorn, a neuropathologist at the VU University Medical Center Amsterdam, is acknowledged for providing figures 7 and 8 .
PY - 2006/5
Y1 - 2006/5
N2 - Vanishing white matter disease (VWM) is one of the most prevalent inherited childhood leucoencephalopathies. The classical phenotype is characterised by early childhood onset of chronic neurological deterioration, dominated by cerebellar ataxia. VWM is unusual because of its clinically evident sensitivity to febrile infections, minor head trauma, and acute fright, which may cause rapid neurological deterioration and unexplained coma. Most patients die a few years after onset. The phenotypic variation is extremely wide, including antenatal onset and early demise and adult-onset, slowly progressive disease. MRI findings are diagnostic in almost all patients and are indicative of vanishing of the cerebral white matter. The basic defect of this striking disease resides in either one of the five subunits of eukaryotic translation initiation factor eIF2B. eIF2B is essential in all cells of the body for protein synthesis and its regulation under different stress conditions. Although the defect is in housekeeping genes, oligodendrocytes and astrocytes are predominantly affected, whereas other cell types are surprisingly spared. Recently, undue activation of the unfolded-protein response has emerged as important in the pathophysiology of VWM, but the selective vulnerability of glia for defects in eIF2B is poorly understood.
AB - Vanishing white matter disease (VWM) is one of the most prevalent inherited childhood leucoencephalopathies. The classical phenotype is characterised by early childhood onset of chronic neurological deterioration, dominated by cerebellar ataxia. VWM is unusual because of its clinically evident sensitivity to febrile infections, minor head trauma, and acute fright, which may cause rapid neurological deterioration and unexplained coma. Most patients die a few years after onset. The phenotypic variation is extremely wide, including antenatal onset and early demise and adult-onset, slowly progressive disease. MRI findings are diagnostic in almost all patients and are indicative of vanishing of the cerebral white matter. The basic defect of this striking disease resides in either one of the five subunits of eukaryotic translation initiation factor eIF2B. eIF2B is essential in all cells of the body for protein synthesis and its regulation under different stress conditions. Although the defect is in housekeeping genes, oligodendrocytes and astrocytes are predominantly affected, whereas other cell types are surprisingly spared. Recently, undue activation of the unfolded-protein response has emerged as important in the pathophysiology of VWM, but the selective vulnerability of glia for defects in eIF2B is poorly understood.
UR - http://www.scopus.com/inward/record.url?scp=33646023388&partnerID=8YFLogxK
U2 - 10.1016/S1474-4422(06)70440-9
DO - 10.1016/S1474-4422(06)70440-9
M3 - Review article
C2 - 16632312
AN - SCOPUS:33646023388
SN - 1474-4422
VL - 5
SP - 413
EP - 423
JO - Lancet Neurology
JF - Lancet Neurology
IS - 5
ER -